A plant extract composite antibacterial agent and its application in oral care products
Through the development of plant extract complex antibacterial agents, combined with ethylhexylglycerol, the problem of imbalance of bacteria and single function caused by oral antibacterial agents in the prior art has been solved, and efficient inhibition and resistance of a variety of pathogenic bacteria have been achieved. The effect of inflammation is safe and gentle.
Patent Information
- Application Number
- CN202410452582.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-04-16
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-04-16
AI Technical Summary
Existing oral antibacterial agents from chemical sources can easily lead to imbalance of oral bacterial flora, single function, and plant-derived antibacterial active ingredients, which are not strong in the antibacterial effect, and are easily affected by surfactants.
Develop a composite antibacterial agent for plant extracts, including hyacinth, cinnamon bark, omethyme, sweet orange and mint extract, etc., combined with ethylhexylglycerol as a synergist, through specific extraction processes and combination ratios, Form a complex antibacterial agent with synergistic antibacterial and anti-inflammatory effects.
It has achieved efficient inhibition of a variety of oral pathogenic bacteria, and has the advantages of being safe, gentle and non-irritating. It can replace traditional antibacterial agents, and it also exhibits a strong antibacterial effect in a system containing surfactant.
Smart Images

Figure BDA0004793126370000061 
Figure BDA0004793126370000072 
Figure BDA0004793126370000131
Abstract
Description
Technical Field
[0001] The invention belongs to the field of oral care, and in particular relates to a plant extract composite antibacterial agent and application thereof in oral care products. Background Art
[0002] With the development of society, people are paying more and more attention to oral problems, and bad breath is the focus of people's attention. Common oral antibacterial agents on the market are chemical antibacterial agents, including metronidazole, chlorhexidine, cetylpyridinium chloride, domiphene, etc. People often have a rejection of traditional chemical antibacterial agents, and traditional chemical antibacterial agents are prone to cause imbalance of oral flora and have single functions. In order to meet consumers' psychological demands for green, healthy and efficient oral antibacterial agents, the development of green and natural oral antibacterial agents has become a hot topic. However, the antibacterial effect of common plant-derived antibacterial active ingredients is not strong, and they cannot effectively inhibit the growth of oral pathogens in a short period of time, and they are easily wrapped by surfactants, affecting the antibacterial performance. Summary of the invention
[0003] In view of the deficiencies in the above-mentioned prior art, the present invention fully utilizes the synergistic effect between antibacterial agents and the synergistic effect of ethylhexylglycerol, has good antibacterial and anti-inflammatory effects, can effectively inhibit the growth of various oral pathogens in a short time, can replace traditional oral antibacterial agents, and has the advantages of being safe, mild and non-irritating.
[0004] The object of the present invention is to provide a plant extract composite antibacterial agent, comprising the following raw materials in percentage by weight: 1-40% of an antibacterial agent and 1-30% of a synergistic enhancer, wherein the antibacterial agent comprises a hyacinth extract, a combination of a hyacinth extract and a composite extract, and the composite extract comprises at least one of a cinnamon bark extract, a thyme extract, a sweet orange extract and a mint extract.
[0005] In some embodiments of the present invention, the plant extract compound antibacterial agent comprises the following raw materials in percentage by weight: 5-40% antibacterial agent and 5-30% synergistic enhancer.
[0006] In some embodiments of the present invention, the plant extract compound antibacterial agent comprises the following raw materials in percentage by weight: 10-40% antibacterial agent and 10-30% synergistic enhancer.
[0007] In some embodiments of the present invention, the plant extract compound antibacterial agent comprises the following raw materials in percentage by weight: 10-30% antibacterial agent and 10-25% synergistic enhancer.
[0008] In some embodiments of the present invention, the extraction process of the cinnamon bark extract comprises the following steps:
[0009] The dried cinnamon bark is crushed, water is added to the cinnamon bark powder, soaked, heated for extraction, extracted, dried, and concentrated to obtain a cinnamon oil extract.
[0010] In some embodiments of the present invention, the mass ratio of the cinnamon bark powder to water is 1:5-15.
[0011] In some embodiments of the present invention, the dried cinnamon bark is crushed and then passed through a 40-60 mesh sieve.
[0012] In some embodiments of the present invention, the soaking time is 18-24 hours.
[0013] In some embodiments of the present invention, the heating extraction is specifically to first heat rapidly with high power, and after steam is generated, reduce the heating power and continue extraction for 4 hours.
[0014] In some embodiments of the present invention, the extraction solvent includes diethyl ether.
[0015] In some embodiments of the present invention, the extraction process of the thyme extract comprises the following steps:
[0016] The dried European thyme is crushed, water is added to the European thyme powder, the mixture is heated for extraction, and the oil layer is separated to obtain the European thyme extract.
[0017] In some embodiments of the present invention, the mass ratio of the thyme powder to water is 1:2-3.
[0018] In some embodiments of the present invention, the heating extraction is specifically to first heat rapidly with high power, and after steam is generated, reduce the heating power and continue extraction for 3 hours.
[0019] In some embodiments of the present invention, the dried wild thyme is crushed and then passed through a 70-90 mesh sieve.
[0020] In some embodiments of the present invention, the extraction process of the sweet orange extract comprises the following steps:
[0021] The dried sweet orange peel is crushed, water is added to the sweet orange peel powder, the mixture is heated for extraction, and the oil layer is separated to obtain the oily sweet orange extract.
[0022] In some embodiments of the present invention, the mass ratio of the sweet orange peel powder to water is 1:2-3.
[0023] In some embodiments of the present invention, the heating extraction is specifically to first heat rapidly with high power, and after steam is generated, reduce the heating power and continue extraction for 2 hours.
[0024] In some embodiments of the present invention, the dried sweet orange peel is crushed and then passed through a 40-60 mesh sieve.
[0025] In some embodiments of the present invention, the extraction process of the peppermint extract comprises the following steps:
[0026] The dried mint stems and leaves are crushed, water is added to the mint stem and leaf powder, the mixture is heated for extraction, and the oil layer is separated to obtain an oily mint extract.
[0027] In some embodiments of the present invention, the mass ratio of the mint stem and leaf powder to water is 1:6-8.
[0028] In some embodiments of the present invention, the heating extraction is specifically to first heat rapidly with high power, and after steam is generated, reduce the heating power and continue extraction for 3 hours.
[0029] In some embodiments of the present invention, the dried mint stems and leaves are crushed and then passed through a 40-60 mesh sieve.
[0030] In some embodiments of the present invention, the extraction process of the hyacinth extract comprises the following steps:
[0031] The dried hyacinth is crushed, ethanol is added to the hyacinth powder for extraction, and the hyacinth powder is concentrated to obtain a hyacinth oily extract.
[0032] In some embodiments of the present invention, the mass ratio of the hyacinth powder to ethanol is 1:1-2.
[0033] In some embodiments of the present invention, the dried hyacinth is crushed and then passed through a 10-30 mesh sieve.
[0034] In some embodiments of the present invention, the extraction temperature is 80-90° C. and the extraction time is 18 to 30 hours.
[0035] In some embodiments of the present invention, the synergist includes ethylhexylglycerin.
[0036] In some embodiments of the present invention, the mass ratio of the hyacinth extract to the composite extract is 1-2:1-9.
[0037] In some embodiments of the present invention, the plant extract composite antibacterial agent further comprises 30-98% of a solvent.
[0038] In some embodiments of the present invention, the solvent includes at least one of 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 1,2-pentanediol, 1,5-pentanediol, isoprene glycol, 1,2-hexanediol, 1,6-hexanediol, ethanol, cypermethrin, water, glycerol, and methylpropanediol.
[0039] Another object of the present invention is to provide a method for preparing a plant extract composite antibacterial agent, comprising the following steps:
[0040] The antibacterial agent, the synergistic enhancer and the solvent are mixed and stirred to obtain the plant extract composite antibacterial agent.
[0041] Another object of the present invention is to provide an application of the plant extract composite antibacterial agent in an oral care product, wherein the oral care product contains the plant extract composite antibacterial agent, and the oral care product includes at least one of a mouthwash and a toothpaste.
[0042] In some embodiments of the present invention, the amount of the plant extract composite antibacterial agent is 0.1-2% by mass.
[0043] Compared with the prior art, the present invention has the following beneficial effects:
[0044] (1) The plant extract composite oral antibacterial agent of the present invention has various components that are common plant extracts, and the active ingredients coordinate and promote each other, have good antibacterial and anti-inflammatory effects, can replace traditional oral antibacterial agents, and have the advantages of being safe, mild, and non-irritating.
[0045] (2) The present invention has a highly effective antibacterial effect under the synergistic effect of ethylhexylglycerol. Even in a system containing a surfactant, it can have a strong inhibitory effect on Escherichia coli, Staphylococcus aureus, Candida albicans, Streptococcus mutans, Fusobacterium nucleatum, and Porphyromonas gingivalis within 1 minute. DETAILED DESCRIPTION
[0046] In order to enable those skilled in the art to better understand the technical solutions of the present invention, the technical solutions of the present invention will be clearly and completely described below in conjunction with the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.
[0047] Example 1
[0048] This embodiment provides an extraction process for cinnamon bark extract, and the specific extraction process is as follows:
[0049] Take 55kg of cinnamon bark, crush it with a Chinese medicine grinder, pass it through a 50-mesh sieve, and obtain cinnamon bark powder. Take 50kg of the sieved cinnamon bark powder, add 5-15 times the amount of distilled water, soak it for 18-24 hours, and then put it into a steam distillation device. First, heat it quickly with high power. After steam is generated, reduce the heating power and continue to extract for 4 hours. The distillate is extracted twice with 50L of ether, the ether layers after the two extractions are combined, and a small amount of anhydrous sodium sulfate is added to dry it. After 20 minutes, heat and evaporate the ether. The obtained cinnamon oil extract is stored in the dark.
[0050] Example 2
[0051] This embodiment provides an extraction process of thyme extract, and the specific extraction process is as follows:
[0052] Take 20 kg of dried European thyme, crush it with a Chinese medicine grinder, pass it through an 80-mesh sieve to obtain European thyme powder, add 2-3 times the amount of deionized water to the European thyme powder, put it into a steam distillation device, first heat it quickly with high power, and after steam is generated, reduce the heating power and continue to extract for 3 hours. Steam out to obtain an oil-water mixture, stand it and separate the oil layer, and you can get the European thyme extract, which is stored in a dark place.
[0053] Example 3
[0054] This embodiment provides an extraction process of peppermint extract, and the specific extraction process is as follows:
[0055] Take 50 kg of dried mint stems and leaves, crush them with a Chinese medicine grinder, pass through a 50-mesh sieve to obtain mint powder, add 6-8 times the amount of deionized water to the mint powder, put it into a steam distillation device, first heat it quickly at high power, and after steam is generated, reduce the heating power and continue to extract for 3 hours. Steam out to obtain an oil-water mixture, stand it and separate the oil layer, and you can get the oily mint extract, which is stored away from light.
[0056] Example 4
[0057] This embodiment provides an extraction process of sweet orange extract, and the specific extraction process is as follows:
[0058] Take 50 kg of dried sweet orange peel, crush it with a Chinese medicine grinder, pass it through a 50-mesh sieve to obtain sweet orange peel powder, add 2-3 times the amount of deionized water to the sweet orange peel powder, put it into a steam distillation device, first heat it quickly with high power, and after steam is generated, reduce the heating power and continue to extract for 2 hours. Steam out to obtain an oil-water mixture, stand it and separate the oil layer, and you can get the oily sweet orange extract, which is stored in the dark.
[0059] Example 5
[0060] This embodiment provides an extraction process for hyacinth extract, and the specific extraction process is as follows:
[0061] Take 3kg of dried hyacinth, crush it with a Chinese medicine grinder, and then pass it through a 20-mesh sieve for later use. Take the sieved hyacinth powder and add it to a Soxhlet extractor, use 1-2 times ethanol (based on the mass of hyacinth powder) as solvent, and reflux extract at a temperature of 80-90℃ for 24 hours. After the extraction is completed, the extract is concentrated under reduced pressure with a rotary evaporator to obtain a hyacinth oily extract and store it in the dark.
[0062] Preparation of plant extract compound antibacterial agent:
[0063] Table 1. Raw material composition of plant extract composite antibacterial agent.
[0064]
[0065] According to the raw materials and mass percentages in Table 1, the above extracts and 1,3-propylene glycol were added to a 250 mL flask of a stirrer, stirred for 30 to 50 min until completely mixed, and insoluble impurities were removed by filtration to obtain a plant extract composite antibacterial agent.
[0066] Suspension quantitative antibacterial test:
[0067] Reference standard: "WST 650-2019 Evaluation method for antibacterial and antibacterial effects".
[0068] Tested bacteria: Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 6526, Candida albicans ATCC 10231, Fusobacterium nucleatum subspecies polynucleate ATCC 25586, Porphyromonas gingivalis 33277, Streptococcus mutans ATCC25175.
[0069] Experimental instruments and equipment: constant temperature incubator, oscillator, finger-shaped bottles, 90mm sterilized dishes, pipettes: 10-100μl, 100-1000μl, 0.5mL-5mL; pipette tips: 10-100μl, 100-1000μl, 0.5mL-5mL.
[0070] Experimental reagents: 0.8% saline, nutrient agar medium, tryptic soy agar medium, Sabouraud agar medium, blood agar medium.
[0071] Preparation of bacterial suspension:
[0072] Table 2. Preparation of bacterial suspension.
[0073]
[0074] The McFarland turbidimetric tube prepared according to the proportion in Table 2 is used as a control for the standard bacterial suspension. Take the fresh culture of the 3rd to 5th generation of the bacterial strain (18 to 24 hours), use a 5mL pipette to draw 3 to 5mL of PBS buffer and add it to the slant test tube, blow and wash repeatedly to wash off the bacterial moss. Subsequently, use a 5mL pipette to transfer the bacterial suspension to another sterile finger-shaped bottle, oscillate on an oscillator for 20 seconds, or tap on the palm of your hand 80 times to make the bacterial suspension uniform. Then add each washed bacterial solution to a sterile test tube of the same diameter (size) as the McFarland turbidimetric standard tube, and add sterile PBS buffer to dilute until the concentration is the same as that of the McFarland turbidimetric standard tube as a bacterial suspension (the bacterial suspension should be stored in a 4°C refrigerator for standby use and should be used on the same day and not overnight).
[0075] Dilute the experimental bacterial suspension appropriately with PBS buffer to the required concentration: take 0.1 mL and drop it into 5.0 mL of the control sample solution (PBS buffer) and the number of recovered bacteria is 1×10 4 ~9×10 4 CFU / mL.
[0076] Experimental steps:
[0077] Experimental sample: 1% aqueous solution of each antibacterial agent in the ratio of Table 1 (including 0.15% CO-40), that is, each antibacterial agent prepared in Table 1 is solubilized with 0.15% CO-40 and prepared into a 1% aqueous solution with sterile deionized water, which is used as experimental sample for standby use;
[0078] Pipette 5.0 mL of the original solution of the experimental sample or its dilution into a sterile finger-shaped bottle;
[0079] Pipette 0.1 mL of the experimental bacterial suspension into a finger-shaped bottle containing 5.0 mL of the sample, mix quickly, and start timing immediately; after 1 minute, take 0.5 mL of the mixture of the experimental bacterial suspension and the sample, add it into a finger-shaped bottle containing 4.5 mL of sterilized PBS buffer, and mix thoroughly;
[0080] After 10 minutes of standing, take 1 mL of the sample solution (or 2-3 dilutions after appropriate dilution) and place it in a sterilized plate. Inoculate two plates for each sample solution or dilution. Pour 15-20 mL of nutrient agar medium (bacteria), Sabouraud agar medium (Candida albicans), blood agar medium (Porphyromonas gingivalis, Fusobacterium nucleatum), and tryptic soy agar medium (Streptococcus mutans) cooled to 40℃-45℃, rotate the plate to make it fully uniform, turn the plate over after the agar solidifies, and culture at (36±1)℃ for 48h (bacteria) and (28±2)℃ for 72h (Candida albicans), and then count the live bacterial colonies.
[0081] Substitute PBS for the test sample and follow the above steps as the control sample; repeat the experiment 3 times and calculate the average value.
[0082] Calculation method: The inhibition rate is calculated according to the following formula.
[0083] Antibacterial rate (%) = (AB) / A×100%
[0084] Where:
[0085] A——average colony count of control samples;
[0086] B——Average colony count of experimental samples.
[0087] Table 3. Antibacterial test results.
[0088] sample Escherichia coli Staphylococcus aureus Candida albicans Streptococcus mutans Fusobacterium nucleatum Example 6 91.36% 81.44% 80.32% 80.54% 80.25% Example 7 92.56% 90.26% 87.68% 88.64% 82.35% Example 8 90.25% 89.36% 86.73% 87.68% 81.49% Example 9 89.34% 87.46% 89.19% 86.43% 80.16% Example 10 99.86% 99.17% 98.93% 99.25% 99.91% Embodiment 11 76.34% 77.46% 69.19% 62.91% 65.25% Example 12 61.56% 72.12% 69.19% 77.13% 77.79% Embodiment 13 79.37% 62.59% 61.19% 66.43% 70.29% Embodiment 14 75.56% 69.59% 66.49% 68.10% 68.83% Embodiment 15 77.78% 72.51% 72.22% 69.14% 67.30% Comparative Example 1 40.77% 37.34% 37.02% 30.94% 33.33% Comparative Example 2 35.62% 42.41% 30.37% 40.36% 43.42% Comparative Example 3 34.93% 28.38% 31.84% 50.00% 26.47% Comparative Example 4 35.16% 27.27% 25.97% 24.03% 22.42% Comparative Example 5 43.65% 27.78% 48.41% 24.61% 21.50% Comparative Example 6 20.96% 25.15% 27.54% 30.07% 27.10%
[0089] As can be seen from Table 3, by comparing the data of Example 6 with Example 11, Example 12, Comparative Examples 1-2, and Comparative Example 6, it can be seen that ethylhexylglycerol has an obvious synergistic antibacterial synergistic effect on hyacinth extract or cinnamon bark extract, there is a synergistic antibacterial synergistic effect between hyacinth extract and cinnamon bark extract, and there is an obvious synergistic antibacterial synergistic effect between hyacinth extract and cinnamon bark extract, and there is an obvious synergistic antibacterial synergistic effect between hyacinth extract and cinnamon bark extract and ethylhexylglycerol; by comparing the data of Example 7 with Example 11, Example 13, Comparative Example 1, Comparative Example 3, and Comparative Example 6, it can be seen that ethylhexylglycerol has an obvious synergistic antibacterial synergistic effect on hyacinth extract or European thyme extract, there is a synergistic antibacterial synergistic effect between hyacinth extract and European thyme extract, and there is an obvious synergistic antibacterial synergistic effect between hyacinth extract and European thyme extract and ethylhexylglycerol; by comparing the data of Example 8 with Example 11, Example 14, Comparative Example 1, Comparison of the data of Example 4 and Comparative Example 6 shows that ethylhexylglycerol has an obvious synergistic antibacterial synergistic effect on hyacinth extract or mint extract, and there is a synergistic antibacterial synergistic effect between hyacinth extract and mint extract, and there is an obvious synergistic antibacterial synergistic effect between hyacinth extract and mint extract, and there is an obvious synergistic antibacterial synergistic effect between hyacinth extract and mint extract and ethylhexylglycerol; Comparison of the data of Example 9 with Example 11, Example 15, Comparative Example 1, and Comparative Examples 5 to 6 shows that ethylhexylglycerol has an obvious synergistic antibacterial synergistic effect on hyacinth extract or sweet orange extract, and there is a synergistic antibacterial synergistic effect between hyacinth extract and sweet orange extract, and there is an obvious synergistic antibacterial synergistic effect between hyacinth extract and sweet orange extract and ethylhexylglycerol; Comparison of the data of Example 10 with Comparative Examples 1 to 6 shows that there is a synergistic antibacterial synergistic effect between cinnamon bark extract, hyacinth extract, European thyme extract, mint extract and sweet orange extract.
[0090] Anti-inflammatory efficacy test:
[0091] Experimental materials: DMEM high-glucose medium, phosphate buffered saline (PBS): pH = 7.3-7.5, trypan blue, Cell Counting Kit-8 (CCK-8), lipopolysaccharide (LPS), dexamethasone, ElisaKit (mouse interleukin 1β (IL-1β) enzyme-linked immunosorbent assay kit, mouse interleukin 6 (IL-6) enzyme-linked immunosorbent assay kit, etc.)
[0092] Cell type used: Mouse monocytic macrophage leukemia cell line (RAW264.7)
[0093] Experimental methods:
[0094] 1. Cell Preparation:
[0095] The RAW246.7 cells were revived and passaged, and the cells were used at passages 3-10.
[0096] 2. Cytotoxicity-Confirmation of Maximum Safe Dosing Concentration:
[0097] Take cells in a stable growth state and adjust the cell concentration to 5×10 5 -6×10 5 / mL, inoculate 100μL per well into a 96-well cell culture plate (except the outermost well and blank control well). Add 200μL PBS to the outermost well of the cell culture plate to reduce the evaporation of the culture medium. Place in a carbon dioxide incubator and culture at 37℃±1℃, 90%±5% humidity, and 5%±1% CO2 concentration. After 24h, observe the cells. If the cell fusion reaches more than 90% of the bottom area of the well, the condition is good, and the next step of the experiment can be carried out.
[0098] 3. Detection of inflammatory factor content:
[0099] 3.1 Cell inoculation: Take cells in the logarithmic growth phase and adjust the concentration to 5×10 with DMEM complete medium without double antibody. 5 ~7×10 5 The cell density should be 45%-60% per well at 24h after inoculation. 500 μL of cell suspension should be added to each well of the 24-well plate and cultured in an incubator at 37±1℃ and 5%±1% CO2 for 24h±1h.
[0100] 3.2 Sample solution configuration:
[0101] Each sample needs to be prepared with a mother solution concentration higher than the final concentration of the sample test for standby use; then transfer an appropriate amount of the sample mother solution and an appropriate amount of the LPS mother solution to mix thoroughly, and make up to the scale to ensure that the final sample concentration is the final concentration of the sample test, and the final concentration of the LPS solution is 1 mg / L. If the sample is a poorly soluble substance, it can be assisted in dissolution by heating, ultrasound, or adding DMSO as a cosolvent.
[0102] 3.3 Induction of drug administration:
[0103] Add each sample solution to a 24-well plate, 500 μL per well, and set up three replicate wells for each concentration in parallel: solvent control, negative control, and positive control. Place the culture plate at 37°C ± 1°C and 5% ± 1% CO2 concentration for 24 ± 1h.
[0104] 3.4 Collect cell supernatant:
[0105] After adding the sample and continuing to culture for 24±1h, collect a sufficient amount of cell supernatant, generally 400μL per tube, divide into 3 tubes, and store in a -80℃ ultra-low temperature refrigerator; the number of subpackages should ensure sufficient test frequency to avoid repeated freezing and thawing.
[0106] 3.5ELISA test:
[0107] Follow the instructions of the ELISA kit to measure the content of inflammatory factors, such as IL-6 and IL-1β. The expression of inflammatory factors after LPS induction may be higher, so before the formal test, the sample dilution ratio should be set, and a preliminary experiment should be conducted to explore and determine the dilution ratio of the experimental test group. Generally speaking, the detection amount of the inflammatory factor IL-1β will not be very high, and the original solution can be used for testing; the inflammatory factor IL-6 is detected in the original solution, and the value will exceed the standard curve range by several times, so when doing this test, the original solution is generally diluted 50 times before testing to ensure that the ELISA detection value falls within the standard curve range.
[0108] 3.6 Statistical analysis
[0109] The software "Curve Expert" was used to fit the standard curve regression equation of "absorbance value-inflammatory factor content" for the standard sample, and the fitting equation regression was fitted using a rational function (Rational Function); the inflammatory factor content corresponding to the absorbance value of each sample to be tested was obtained through the fitting equation. The software "IBMSPSS Statistics 26" was used to compare and analyze the general average value of the inflammatory factor content of each sample to be tested, and the T test method was used between each group to analyze whether the final analysis sample was significant (P value). And the inhibition rate of each sample to be tested was calculated.
[0110] The inhibition rate was calculated according to formula (1):
[0111] Inhibition rate (%) = (1-T / C) × 100% …………………… (1)
[0112] Where:
[0113] T—average value of inflammatory factor content of the test substance
[0114] C—Average value of inflammatory factor content in negative control
[0115] 3.7 Test validity:
[0116] The inflammatory factor content of the negative control under the action of LPS was significantly different from that of the solvent control;
[0117] The inhibition rate of positive control inflammatory factors was ≥25%.
[0118] 3.8 Result determination:
[0119] The content of inflammatory factors (such as IL-1β, IL-6) in the sample at a certain tested concentration is expressed as: the mean value of the inflammatory factor content ± the standard deviation (SD) of the inflammatory factor content.
[0120] The ability of the sample to inhibit the production of inflammatory factors at a certain tested concentration was evaluated as follows: compared with the NC group, whether the sample had the ability to significantly inhibit the secretion of inflammatory factors at the tested concentration, with the P value as the final judgment: P < 0.05 indicated a significant difference, indicated by *; P < 0.01 indicated an extremely significant difference, indicated by **, and the inhibition rate was used as a reference for the ability to inhibit the secretion of inflammatory factors.
[0121] Table 4. Anti-inflammatory efficacy test results.
[0122]
[0123]
[0124] As shown in Table 4, by comparing the data of Example 6 with Comparative Examples 1-2 and Comparative Example 6, it can be seen that ethylhexylglycerol has a significant synergistic anti-inflammatory effect on hyacinth extract or cinnamon bark extract, there is a synergistic anti-inflammatory effect between hyacinth extract and cinnamon bark extract, and there is a significant synergistic anti-inflammatory effect between hyacinth extract and cinnamon bark extract, and there is a significant synergistic anti-inflammatory effect between hyacinth extract and cinnamon bark extract and ethylhexylglycerol; by comparing the data of Example 7 with Comparative Example 1, Comparative Example 3, and Comparative Example 6, it can be seen that ethylhexylglycerol has a significant synergistic anti-inflammatory effect on hyacinth extract or thyme extract, there is a synergistic anti-inflammatory effect between hyacinth extract and thyme extract, and there is a significant synergistic anti-inflammatory effect between hyacinth extract and thyme extract, and there is a significant synergistic anti-inflammatory effect between hyacinth extract and thyme extract and ethylhexylglycerol; by comparing the data of Example 8 with Comparative Examples 1, Comparative Example 4, and Comparative Example 6 It can be seen that ethylhexylglycerol has an obvious synergistic anti-inflammatory and synergistic effect on hyacinth extract or mint extract, there is a synergistic anti-inflammatory and synergistic effect between hyacinth extract and mint extract, and there is an obvious synergistic anti-inflammatory and synergistic effect between hyacinth extract, mint extract and ethylhexylglycerol; from the data comparison of Example 9 with Comparative Example 1 and Comparative Examples 5 to 6, it can be seen that ethylhexylglycerol has an obvious synergistic anti-inflammatory and synergistic effect on hyacinth extract or sweet orange extract, there is a synergistic anti-inflammatory and synergistic effect between hyacinth extract and sweet orange extract, and there is an obvious synergistic anti-inflammatory and synergistic effect between hyacinth extract, sweet orange extract and ethylhexylglycerol; from the data comparison of Example 10 with Comparative Examples 1 to 6, it can be seen that there is a synergistic anti-inflammatory and synergistic effect between cinnamon bark extract, hyacinth extract, thyme extract, mint extract and sweet orange extract.
[0125] In the plant extract composite antibacterial agent of the present invention, the mass percentage of the antibacterial agent is in the range of 1-40%, the mass percentage of the synergist is in the range of 1-30%, and the mass percentage of the solvent is in the range of 30-98%, and / or other solvents are used to extract hyacinth extract, cinnamon bark extract, thyme flower extract, sweet orange extract, and mint extract, and / or other solvents are selected for the plant extract composite antibacterial agent. The obtained plant extract composite antibacterial agent has synergistic antibacterial and synergistic anti-inflammatory effects between the antibacterial agents, the synergist has obvious synergistic enhancing effects on the antibacterial agent, and the plant extract composite antibacterial agent is used in the preparation of oral care products, which has the advantages of safety, mildness, and no stimulation.
[0126] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the above embodiments, ordinary technicians in the relevant field should understand that after reading the specification of this application, the technicians can still modify or replace the specific implementation mode of the present invention with equivalents, but these modifications or changes do not deviate from the scope of protection of the pending claims of the present application.
Claims
1. A plant extract composite antibacterial agent, characterized in that: The invention is composed of the following raw materials in percentage by weight: 1-40% of an antibacterial agent, 1-30% of a synergist and 30-98% of a solvent, wherein the antibacterial agent is selected from hyacinth extract or a combination of hyacinth extract and a composite extract, wherein the composite extract is selected from at least one of cinnamon bark extract, thyme extract, sweet orange extract and mint extract; the synergist is selected from ethylhexylglycerol; and the solvent is selected from at least one of 1,2-propylene glycol, 1,3-propylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, 1,2-pentanediol, 1,5-pentanediol, isopentyl glycol, 1,2-hexanediol, 1,6-hexanediol, ethanol, glycerol and methylpropanediol.
2. The plant extract composite antibacterial agent according to claim 1, characterized in that The plant extract composite antibacterial agent comprises the following raw materials in percentage by mass: 5-40% of antibacterial agent and 5-30% of synergistic enhancer.
3. The plant extract composite antibacterial agent according to claim 2, characterized in that: The plant extract composite antibacterial agent comprises the following raw materials in percentage by mass: 10-30% of the antibacterial agent and 10-25% of the synergistic enhancer.
4. The plant extract composite antibacterial agent according to claim 1, characterized in that The extraction process of the hyacinth extract comprises the following steps: The dried hyacinth is crushed, ethanol is added to the hyacinth powder for extraction, and the hyacinth powder is concentrated to obtain a hyacinth oily extract; And / or, the extraction process of the cinnamon bark extract comprises the following steps: The dried cinnamon bark is crushed, water is added to the cinnamon bark powder, soaked, heated for extraction, extracted, dried, and concentrated to obtain a cinnamon oil extract; And / or, the extraction process of the thyme extract comprises the following steps: The dried European thyme is crushed, water is added to the European thyme powder, and the mixture is heated for extraction, and the oil layer is separated to obtain the European thyme extract; And / or, the extraction process of the sweet orange extract comprises the following steps: The dried sweet orange peel is crushed, water is added to the sweet orange peel powder, and the mixture is heated for extraction, and the oil layer is separated to obtain an oily sweet orange extract; And / or, the extraction process of the peppermint extract comprises the following steps: The dried mint stems and leaves are crushed, water is added to the mint stem and leaf powder, the mixture is heated for extraction, and the oil layer is separated to obtain an oily mint extract.
5. The plant extract composite antibacterial agent according to claim 1, characterized in that: The mass ratio of the hyacinth extract to the composite extract is 1-2:1-9.
6. Use of the plant extract composite antibacterial agent according to any one of claims 1 to 5 in the preparation of oral care products, characterized in that: The oral care product contains the plant extract composite antibacterial agent, and the oral care product includes at least one of a mouthwash and a toothpaste.
7. Use of the plant extract composite antibacterial agent according to claim 6 in the preparation of oral care products, characterized in that: In terms of mass percentage, the dosage of the plant extract composite antibacterial agent is 0.1-2%.
